Premium
Identifying existing health care services that do not provide value for money
Author(s) -
Elshaug Adam G,
Moss John R,
Littlejohns Peter,
Kar Jonathan,
Merlin Tracy L,
Hiller Janet E
Publication year - 2009
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2009.tb02394.x
Subject(s) - scarcity , health care , business , context (archaeology) , psychological intervention , identification (biology) , subsidy , risk analysis (engineering) , cost effectiveness , health care rationing , quality (philosophy) , population , public economics , medicine , nursing , environmental health , economics , economic growth , paleontology , botany , microeconomics , philosophy , epistemology , market economy , biology
Health systems can be improved appreciably by making them more efficient and accountable, and enhancing the quality of care, without necessarily requiring additional resources. Australia, like other nations, cannot escape making difficult health care choices in the context of resource scarcity, and the challenge of delivering quality care, informed by best available evidence, to an ageing population with multiple comorbidities. An opportunity exists for a cost‐saving or cost‐neutral agenda of reallocation of resources within the existing health budget, through reducing the use of existing health care interventions that offer little or no benefit relative to the cost of their public subsidy. This would allow reallocation of funding towards interventions that are more cost‐effective, maximising health gain. Criteria based on those developed for health technology assessment (HTA) might facilitate the systematic and transparent identification of existing, potentially ineffective practices on which to prioritise candidates for assessment as to their cost‐effectiveness. The process could be jointly funded by all relevant stakeholders but centrally administered, with HTA groups resourced to undertake identification and assessment and to liaise with clinicians, consumers and funding stakeholders.